Edwards Lifesciences Transcatheter Heart Valve Therapies Research Grant (IIS)

About this program

Edwards Lifesciences offers Investigator-Initiated Study (IIS) funding to advance clinical knowledge in transcatheter heart valve therapies, with stated areas of interest including M‑TEER and transcatheter tricuspid valve replacement. Support is intended for proposals that address meaningful scientific or clinical questions consistent with Edwards’ priorities—disease prevalence and progression, improving clinical outcomes, expanding patient populations and indications, and improving cost pathways. Applicants must be investigators submitting IIS protocols directly relevant to transcatheter valve therapy and demonstrate that their proposal aligns with the listed areas of focus for consideration.